99% Savings - Buy Just @1 Rs X
Rabecom (Common) is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Acidity. Rabecom (Common) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Rabecom (Common) is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The most common side effects of Rabecom (Common) are Diarrhoea. Besides the aforementioned side effects, there are other adverse effects of Rabecom (Common) as well, which are listed below. These side effects of Rabecom (Common) are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Rabecom (Common) is Safe for pregnant women and Moderate for women who are breastfeeding. It is important to know if Rabecom (Common) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rabecom (Common) related warnings section.
Rabecom (Common) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rabecom (Common) in conditions like Diarrhea (Loose Motions). Other contraindications of Rabecom (Common) have been discussed in the sections ahead.
Drug reaction of Rabecom (Common) with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rabecom (Common) is considered not safe while driving, and is not addictive.
Rabecom (Common) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Rabecom (Common) safe for pregnant women?
Rabecom (Common) is safe for pregnant women.
Is the use of Rabecom (Common) safe during breastfeeding?
Breastfeeding women may feel side effects of Rabecom (Common). If you see any side effects, stop taking Rabecom (Common) immediately and talk to your doctor. Take Rabecom (Common) again, only after your doctor's advice.
What is the effect of Rabecom (Common) on the Kidneys?
Rabecom (Common) is completely safe for kidneys.
What is the effect of Rabecom (Common) on the Liver?
Rabecom (Common) has very mild side effects on the liver.
What is the effect of Rabecom (Common) on the Heart?
There are no any side effects of Rabecom (Common) for the heart.
Rabecom (Common) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rabecom (Common) unless your doctor advises you to do so -
Is this Rabecom (Common) habit forming or addictive?
Rabecom (Common) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rabecom (Common), you should not drive or work on any heavy machine, as Rabecom (Common) can make you drowsy.
Is it safe?
There are no side effects of Rabecom (Common), so it is safe for use.
Is it able to treat mental disorders?
Rabecom (Common) is unable to treat or cure mental disorders.
Interaction between Food and Rabecom (Common)
You can take Rabecom (Common) with food.
Interaction between Alcohol and Rabecom (Common)
Consuming Rabecom (Common) with alcohol can have many serious effects on your body.
Yes, Rabecom (Common) use is associated with the development of diarrhea. This might be related to an infection caused by Clostridium difficile. If you experience severe diarrhea after consuming this medicine, inform the doctor right away without further delay. In addition, one must take a lot of electrolytes and fluids for preventing dehydration. Taking an anti-diarrheal medication may also help.
Yes, Rabecom (Common) might lead to low magnesium levels in persons who take it for at least 3 months. Magnesium helps in absorption of vitamin D and calcium, low level of magnesium will affect the absorption of Vit. D and calcium lead to decrease bone density and increases the risk of bone fracture. Low-level magnesium can be managed by taking a dietary supplement which is rich in magnesium.
No, Rabecom (Common) is not an antibiotic. It belongs to the group of medications called proton pump inhibitor which blocks the excessive acid secretion in the stomach while antibiotics are the medicine that prevents and treats the infection caused by bacteria.
Yes, Rabecom (Common) is safe to take as long as it is prescribed by your doctor. However, in some people, it may produce some side effects like a headache, diarrhea, constipation, nausea, vomiting, sore throat and gas. If you suffer from any side effects, please inform your doctor immediately.
Rabecom (Common) is available in tablet, capsule and injection form. It should be taken exactly as prescribed by your doctor. It can be taken with or without food because food does not affect the absorption of the drug. It should be taken the whole and swallowed with water. It should not be chewed, crushed or split. It should be taken at exactly the same time every day so that there is less chance of missing the dose.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078